1 - 4 of 4
Number of results to display per page
Search Results
2. More Room for European Agencies in the EU Decision-Making Process?
- Author:
- Basile Ridard
- Publication Date:
- 09-2018
- Content Type:
- Working Paper
- Institution:
- EGMONT - The Royal Institute for International Relations
- Abstract:
- The European institutions are not always able to address crises in a timely manner due to the cumbersome decision-making process. European agencies often provide the most appropriate response to the concerns of citizens and businesses that are experienced across the single market. They should be granted greater autonomy to bring to life EU policies while being made more responsible. At a time of growing uncertainties, the EU needs to further develop existing EU agencies and create new ones for addressing new cross-border challenges. A common legal framework should also be created for all EU agencies in order to harmonize their overall functioning.
- Topic:
- Regional Cooperation, European Union, Legal Theory, and Medicine
- Political Geography:
- Europe
3. US and Russia Can End Use of Weapons-Usable Uranium for Medical Uses
- Author:
- Miles A. Pomper
- Publication Date:
- 02-2014
- Content Type:
- Working Paper
- Institution:
- James Martin Center for Nonproliferation Studies
- Abstract:
- A new report co-authored by CNS Senior Research Associate Miles Pomper recommends steps for the United States and Russia to cooperate in ending Russian use of highly enriched uranium (HEU) in medical isotope production, an important step in keeping this nuclear weapons material from terrorists. Great progress has been achieved in recent years in minimizing civilian use of HEU as part of the international efforts to reduce the nuclear terrorism threat. In particular, the leading global suppliers of the molybdenum-99 (Mo-99) isotope, which is widely used in medical diagnostics, are taking steps to reduce and, in the medium time frame, completely eliminate the use of HEU in the production of medical isotopes. Major new steps towards phasing out HEU use in medical isotopes production could be announced at the Nuclear Security Summit that will take place in The Hague on March 24-25, 2014. The Russian nuclear industry has set for itself an ambitious goal of becoming one of the three top global suppliers of Mo-99, used in 80 per cent of the medical procedures involving isotopes particularly as a diagnostic tool. Growing Russian production could help stabilize the global Mo-99 market, which faced severe shortages on several occasions in 2005-2013. According to some estimates, in 2010 during a six month period medical facilities around the world were unable to perform diagnostic procedures for several million people due to the shortage of Mo-99; the shortfall was estimated at 7 million doses. However, until recently, Russia had been bucking global trends by planning to use HEU fuels and targets rather than safer low enriched uranium (LEU) for much of this production. The ‘Ending HEU Use in Medical Isotope Production: Options for Russian-US Cooperation’ report co-authored by the Moscow-based Center for Energy for Energy and Security Studies (CENESS) analyses what can be done by Moscow and Washington to harmonize the Russian producers’ plans to win a share of the global market, while at the same time facilitating the Russian nuclear industry’s transition to new market requirements for producing Mo-99 without HEU.
- Topic:
- Diplomacy, Nuclear Weapons, Nuclear Power, Nonproliferation, and Medicine
- Political Geography:
- Russia, Europe, North America, and United States of America
4. Stories of the Soviet Anti-Plague System
- Author:
- Raymond A. Zilinskas, James W. Toppin, and Casey W. Mahoney
- Publication Date:
- 09-2013
- Content Type:
- Working Paper
- Institution:
- James Martin Center for Nonproliferation Studies
- Abstract:
- Throughout the 20th century, the USSR Ministry of Health’s 2nd Directorate headed an “anti-plague (AP) system” whose main objective was to protect the country from endemic and imported dread diseases such as plague, anthrax, and others. In addition, it had an important, two-phased role in the Soviet Union’s biological warfare (BW) program—to provide training to the BW program’s scientific workers on biosafety practices and to submit cultures of especially virulent pathogens to that program’s research and development institutions. Because the USSR considered information about endemic infectious disease, as well as BW-related activity, to be state secrets, hardly any outsiders knew about the AP system’s work and scientific accomplishments. To this day, the five Russian AP institutes remain closed to outsiders and are almost as secretive about their current activities as they were during the Soviet era.
- Topic:
- Health, Science and Technology, Public Health, Pandemic, and Medicine
- Political Geography:
- Europe and Soviet Union